• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    23 Stocks Moving in Friday's Pre-Market Session

    5/13/22 7:52:46 AM ET
    $AFRM
    $ALNA
    $CALA
    $DC
    Finance: Consumer Services
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AFRM alert in real time by email

    Gainers

    • OTR Acquisition Corp. (NASDAQ:OTRA) rose 88.7% to $18.21 in pre-market trading after filing on Thursday showed shareholders approved merger with Comera Life Sciences.
    • Calithera Biosciences, Inc. (NASDAQ:CALA) rose 46.3% to $0.2358 in pre-market trading. The company recently reported a net loss of $13.8 million for the three months ended March 31, 2022.
    • Affirm Holdings, Inc. (NASDAQ:AFRM) shares rose 31.2% to $23.66 in pre-market trading after the company reported upbeat results for its third quarter and raised its revenue forecast for the fiscal year. The company also announced a multi-year extension of its partnership in the U.S. with Shopify.
    • Molecular Partners AG (NASDAQ:MOLN) rose 28.2% to $7.79 in pre-market trading. Molecular Partners recently said its partner Novartis expects the FDA may require additional clinical data for the Emergency Use Application for ensovibep.
    • Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) rose 22.5% to $0.1630 in pre-market trading after jumping over 70% on Thursday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.
    • Robinhood Markets, Inc. (NASDAQ:HOOD) shares rose 22% to $10.46 in pre-market trading after a 13D filing showed Samuel Bankman-Fried, founder and CEO of FTX crypto exchange, disclosed a 7.6% stake in the company.
    • Landos Biopharma, Inc. (NASDAQ:LABP) rose 19% to $0.7959 in pre-market trading after the company said Q1 EPS results were higher year over year.
    • Duolingo, Inc. (NASDAQ:DUOL) rose 17.6% to $78.81 in pre-market trading after the company reported better-than-expected Q1 EPS and sales results.
    • Molecular Data Inc. (NASDAQ:MKD) rose 14.6% to $0.1044 in pre-market trading after jumping around 17% on Thursday.
    • SciSparc Ltd. (NASDAQ:SPRC) rose 13.4% to $3.29 in pre-market trading after jumping 23% on Thursday.
    • KULR Technology Group, Inc. (NASDAQ:KULR) rose 13.1% to $1.38 in pre-market trading after dropping 4% on Thursday.
    • McEwen Mining Inc. (NYSE:MUX) rose 12.1% to $0.5167 in pre-market trading. McEwen Mining recently posted a Q1 loss of $0.04 per share.
    • Redwire Corporation (NYSE:RDW) rose 10.8% to $4.10 in pre-market trading following Q1 results.
    • Fangdd Network Group Ltd. (NASDAQ:DUO) rose 9.3% to $0.2352 in pre-market trading after gaining around 8% on Thursday.
    • The RealReal, Inc. (NASDAQ:REAL) rose 9.3% to $3.52 in pre-market trading after dipping around 6% on Thursday.

    Don’t forget to check out our premarket coverage here .

    Losers

    • LiqTech International, Inc. (NASDAQ:LIQT) shares fell 48.6% to $0.47 in pre-market trading after the company priced its public offering of common stock and pre-funded warrants.
    • FIGS, Inc. (NYSE:FIGS) shares fell 25.1% to $9.62 in pre-market trading after the company reported worse-than-expected Q1 adjusted EPS and sales results and cut FY22 sales guidance to below analyst estimates.
    • Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) shares fell 14.4% to $0.19 in pre-market trading. Salarius Pharmaceuticals posted a Q1 loss of $0.13 per share.
    • Twitter, Inc. (NYSE:TWTR) fell 14.2% to $38.70 in pre-market trading. After running the hard mile to mobilize finances for his Twitter buy, Elon Musk said early Friday the deal is on hold.
    • Stealth BioTherapeutics Corp (NASDAQ:MITO) fell 9.5% to $0.2262 in pre-market trading. Stealth BioTherapeutics shares jumped around 32% on Thursday after the company announced the FDA has granted Orphan Drug Designation for elamipretide for the treatment duchenne muscular dystrophy.
    • Dakota Gold Corp. (NYSE:DC) fell 9.3% to $2.90 in pre-market trading after dipping 6% on Thursday.
    • Regulus Therapeutics Inc. (NASDAQ:RGLS) fell 8.4% to $0.2250 in pre-market trading. Regulus Therapeutics posted a Q1 loss of $0.05 per share.
    • Sky Harbour Group Corporation (NYSE:SKYH) fell 6.7% to $8.05 in pre-market trading after reporting Q1 results.
    Get the next $AFRM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AFRM
    $ALNA
    $CALA
    $DC

    CompanyDatePrice TargetRatingAnalyst
    Affirm Holdings Inc.
    $AFRM
    2/3/2026$76.00Equal-Weight → Overweight
    Morgan Stanley
    Molecular Partners AG
    $MOLN
    1/27/2026$13.00Buy
    H.C. Wainwright
    Affirm Holdings Inc.
    $AFRM
    1/27/2026$100.00Hold → Buy
    Needham
    Robinhood Markets Inc.
    $HOOD
    1/9/2026$145.00Buy
    Argus
    Duolingo Inc.
    $DUOL
    1/6/2026$245.00Buy
    Truist
    Dakota Gold Corp.
    $DC
    1/5/2026$9.75Buy
    H.C. Wainwright
    Duolingo Inc.
    $DUOL
    1/5/2026$250.00Neutral → Buy
    BofA Securities
    Robinhood Markets Inc.
    $HOOD
    12/29/2025$145.00 → $135.00Buy
    Needham
    More analyst ratings

    $AFRM
    $ALNA
    $CALA
    $DC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hanish Arnold C bought $3,740 worth of shares (5,000 units at $0.75) (SEC Form 4)

    4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)

    11/24/25 5:08:13 PM ET
    $SLRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Exec VP Finance, CFO Rosenblum Mark J bought $16,000 worth of shares (20,000 units at $0.80), increasing direct ownership by 11,299% to 20,177 units (SEC Form 4)

    4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)

    11/20/25 4:42:09 PM ET
    $SLRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP, GC and Secretary Futch Aaron Michael bought $100,337 worth of shares (18,410 units at $5.45) (SEC Form 4)

    4 - Redwire Corp (0001819810) (Issuer)

    11/14/25 4:07:20 PM ET
    $RDW
    Military/Government/Technical
    Industrials

    $AFRM
    $ALNA
    $CALA
    $DC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer Gallagher Daniel Martin Jr sold $870,665 worth of shares (10,000 units at $87.07), decreasing direct ownership by 2% to 393,612 units (SEC Form 4)

    4 - Robinhood Markets, Inc. (0001783879) (Issuer)

    2/5/26 4:31:01 PM ET
    $HOOD
    Investment Bankers/Brokers/Service
    Finance

    Chief Brokerage Officer Quirk Steven M. sold $4,613,285 worth of shares (52,540 units at $87.81), decreasing direct ownership by 66% to 27,564 units (SEC Form 4)

    4 - Robinhood Markets, Inc. (0001783879) (Issuer)

    2/5/26 4:30:31 PM ET
    $HOOD
    Investment Bankers/Brokers/Service
    Finance

    Director Ae Red Holdings, Llc sold $37,664,336 worth of shares (3,368,903 units at $11.18) (SEC Form 4)

    4 - Redwire Corp (0001819810) (Issuer)

    2/5/26 4:17:26 PM ET
    $RDW
    Military/Government/Technical
    Industrials

    $AFRM
    $ALNA
    $CALA
    $DC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Affirm upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Affirm from Equal-Weight to Overweight and set a new price target of $76.00

    2/3/26 6:49:01 AM ET
    $AFRM
    Finance: Consumer Services
    Finance

    H.C. Wainwright initiated coverage on Molecular Partners AG with a new price target

    H.C. Wainwright initiated coverage of Molecular Partners AG with a rating of Buy and set a new price target of $13.00

    1/27/26 8:47:34 AM ET
    $MOLN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Affirm upgraded by Needham with a new price target

    Needham upgraded Affirm from Hold to Buy and set a new price target of $100.00

    1/27/26 8:33:32 AM ET
    $AFRM
    Finance: Consumer Services
    Finance

    $AFRM
    $ALNA
    $CALA
    $DC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Affirm and Virgin Media O2 partner to bring flexible financing to O2 customers

    Affirm and Virgin Media O2 are today announcing a new partnership that will see the transparent and flexible payment network provide upfront and honest hardware financing to O2 - one of the UK's leading mobile providers. Through the partnership, new and existing O2 customers will be able to enjoy increased flexibility to choose a payment option that suits their needs when purchasing a device. Affirm will provide financing options for mobile phones and other hardware, including headphones and games consoles, offering a wide choice of monthly payment plans. Customers who take out one of these payment plans will never be charged late or hidden fees when paying off their loan, and unlike pa

    2/6/26 3:00:00 AM ET
    $AFRM
    Finance: Consumer Services
    Finance

    Affirm reports second fiscal quarter 2026 results

    Affirm Holdings, Inc. (NASDAQ:AFRM) ("Affirm" or the "Company") today reported financial results for its fiscal 2026 second quarter ended December 31, 2025. The results, which include a shareholder letter furnished to the U.S. Securities and Exchange Commission on Form 8-K, can be found in the "Quarterly Results" section of the Company's investor relations website at https://investors.affirm.com/. Affirm will host a conference call and webcast to discuss its financial results today at 2:00pm PT. Hosting the call will be Max Levchin, Founder and Chief Executive Officer, Michael Linford, Chief Operating Officer, and Rob O'Hare, Chief Financial Officer. The conference call will be webcast li

    2/5/26 4:30:00 PM ET
    $AFRM
    Finance: Consumer Services
    Finance

    Affirm and Wayfair expand partnership to the UK and Canada

    Affirm (NASDAQ:AFRM) today announced the expansion of its partnership with Wayfair (NYSE:W), bringing its honest financial products to shoppers in the UK and Canada. Whether shopping for a new dining table or the perfect sofa, approved shoppers in the UK and Canada can now split their purchases with Affirm. The experience is straightforward: customers receive a quick, real-time approval decision and can choose the payment plan that fits their needs. Affirm never charges late fees or hidden fees, and there is no compounding interest. Customers only pay what they agree to. Today's announcement builds on the companies' recently expanded partnership, which brought Affirm to Wayfair's onli

    2/5/26 4:15:00 PM ET
    $AFRM
    $W
    Finance: Consumer Services
    Finance
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AFRM
    $ALNA
    $CALA
    $DC
    SEC Filings

    View All

    SEC Form 144 filed by FIGS Inc.

    144 - FIGS, Inc. (0001846576) (Subject)

    2/5/26 8:37:25 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    SEC Form 10-Q filed by Affirm Holdings Inc.

    10-Q - Affirm Holdings, Inc. (0001820953) (Filer)

    2/5/26 5:04:56 PM ET
    $AFRM
    Finance: Consumer Services
    Finance

    Affirm Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Affirm Holdings, Inc. (0001820953) (Filer)

    2/5/26 4:09:12 PM ET
    $AFRM
    Finance: Consumer Services
    Finance

    $AFRM
    $ALNA
    $CALA
    $DC
    Leadership Updates

    Live Leadership Updates

    View All

    Redwire Announces Planned Board Refreshment

    General (RET) James McConville and Dorothy D. Hayes to Join as Independent Directors; Jonathan Baliff and John S. Bolton to Step Down from the Board, Effective Immediately Redwire Corporation (NYSE:RDW) ("Redwire" or the "Company"), a global leader in space and defense technology solutions, today announced a planned Board of Directors refreshment. Redwire's Board of Directors has appointed General (RET) James McConville and Dorothy D. Hayes as new independent directors. Jonathan Baliff and John S. Bolton, who joined the Board as part of Redwire's combination with Genesis Park Acquisition Corp. in 2021, have stepped down from the Board. These Board changes are effective immediately. Ge

    10/7/25 7:31:00 AM ET
    $RDW
    Military/Government/Technical
    Industrials

    Redwire Announces CFO Retirement and Plan for Succession

    Jonathan Baliff to Retire as Chief Financial Officer on November 30, 2025; current Chief Accounting Officer Chris Edmunds Planned Successor Redwire Corporation (NYSE:RDW) ("Redwire" or the "Company"), a global leader in space and defense technology solutions, today announced that Jonathan Baliff, the Company's Chief Financial Officer, will retire effective November 30, 2025. In connection with Mr. Baliff's retirement, the Board plans to appoint Chris Edmunds, who is currently serving as the Company's Senior Vice President and Chief Accounting Officer, to succeed Mr. Baliff. Mr. Baliff will serve as a consultant to the Company through December 2026 to support a smooth transition. Mr. Edm

    10/7/25 7:30:00 AM ET
    $RDW
    Military/Government/Technical
    Industrials

    Ian Ball Appointed Vice-Chairman of McEwen Inc.

    TORONTO, Sept. 11, 2025 (GLOBE NEWSWIRE) -- McEwen Inc. (NYSE:MUX) (TSX:MUX) ("McEwen" or "MUX") is pleased to announce the appointment of Ian Ball as the Company's Vice-Chairman, a newly created executive position designed to support the Company's strategic growth. Prior to assuming this role, Mr. Ball has served as an independent director of McEwen since 2022. His appointment reflects the Company's commitment to strengthening leadership as it advances its production and exploration goals. From 2014 to 2021, Mr. Ball was President and then CEO of Abitibi Royalties Inc., where he led the company to a remarkable Compounded Annual Growth Rate (CAGR) of 74% for its share price,

    9/11/25 6:00:00 AM ET
    $MUX
    Precious Metals
    Basic Materials

    $AFRM
    $ALNA
    $CALA
    $DC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Fangdd Network Group Ltd.

    SC 13G - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:26:40 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13G/A filed by Fangdd Network Group Ltd.

    SC 13G/A - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:24:27 PM ET
    $DUO
    Real Estate
    Finance

    SEC Form SC 13D filed by LiqTech International Inc.

    SC 13D - LIQTECH INTERNATIONAL INC (0001307579) (Subject)

    11/19/24 2:36:38 PM ET
    $LIQT
    Industrial Machinery/Components
    Technology

    $AFRM
    $ALNA
    $CALA
    $DC
    Financials

    Live finance-specific insights

    View All

    Affirm reports second fiscal quarter 2026 results

    Affirm Holdings, Inc. (NASDAQ:AFRM) ("Affirm" or the "Company") today reported financial results for its fiscal 2026 second quarter ended December 31, 2025. The results, which include a shareholder letter furnished to the U.S. Securities and Exchange Commission on Form 8-K, can be found in the "Quarterly Results" section of the Company's investor relations website at https://investors.affirm.com/. Affirm will host a conference call and webcast to discuss its financial results today at 2:00pm PT. Hosting the call will be Max Levchin, Founder and Chief Executive Officer, Michael Linford, Chief Operating Officer, and Rob O'Hare, Chief Financial Officer. The conference call will be webcast li

    2/5/26 4:30:00 PM ET
    $AFRM
    Finance: Consumer Services
    Finance

    FIGS Announces Date of Fourth Quarter and Full Year 2025 Earnings Release, Conference Call and Webcast

    FIGS, Inc. (NYSE:FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced it will release its fourth quarter and full year 2025 financial results on Thursday, February 26, 2026, after U.S. markets close. FIGS management will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial and business results and outlook. Prior to the call, FIGS will publish a fourth quarter and full year 2025 financial highlights presentation on its investor relations website at https://ir.wearfigs.com/financials/quarterly-results/default.aspx. FIGS Fourth Quarter and Full Year 2025 Earnings and Conference Call

    2/5/26 4:05:00 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    Molecular Partners Announces Presentation of First Imaging and Dosimetry Data of DLL3-Targeting Radiotherapy MP0712 in Patients at TWC 2026

    Specific tumor accumulation and attractive biodistribution highly supportive of MP0712 clinical development for treatment of DLL3-expressing cancersDosimetry data highlight Radio-DARPins as vector for precise delivery of potent alpha-emitting isotopes to tumorsMP0712 Phase 1/2a study open in U.S. with initial clinical data expected in 2026Molecular Partners to host conference call February 2 at 8AM ET (2PM CET), joined by renowned nuclear medicine expert Prof. Ken Herrmann, M.D. ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG ((SIX: MOLN, NASDAQ:MOLN), a clinical-stage biotech company deve

    2/2/26 1:00:00 AM ET
    $MOLN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care